MRKR

Marker Therapeutics, Inc.

Healthcare · Biotechnology

$255.39 sample

-3.01 (-1.16%) 1D

Market cap

$1.25T

Price as of

2026-10-15

Latest filing

8-K · 2026-10-01

Alerts

8

Price$255.39 +8.19% 3M daily closessample

266.42236.05

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 12INSInsider buy: Director
Oct 01SEC8-K filed: material event
Sep 25INSInsider sell: Chief Financial Officer
Sep 17INSInsider sell: General Counsel
Sep 08SECForm 144 filed
Sep 01INSInsider sell: 10% owner
Aug 26INSInsider buy: General Counsel
Aug 17INSInsider buy: Chief Financial Officer

Sign up to see the real MRKR record →

Company facts

SEC EDGAR registration

Name: Marker Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +15sample, -100 to +100
Reporting currency: USD

Who is positioning in MRKR

sample

Insiders: 25 insider transactions over 90 days, net selling, $619.1M
Congress: 3 members traded over 90 days
Institutions · 13F: 31 funds hold $11.3B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$44.2B +17.5% y/y

Q4 2024Q3 2026

Inventory$26.2B +12.5% y/y

Q4 2024Q3 2026

Accounts receivable$20.8B +9.6% y/y

Q4 2024Q3 2026

Total debt$54.6B +12.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $401.6B +10.2% 3M
Sample peer B: $611.8B +0.6% 3M
Sample peer C: $322.9B -9.1% 3M
Sample peer D: $618.3B +13.0% 3M
Sample peer E: $366.1B -1.0% 3M